Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL6775232

CN(C)C(=O)c1ccc(C(=O)NCCCOc2ccc3ccnc(N)c3c2)cc1.O=C(O)C(F)(F)F

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAD52 P43351 1/20 0.42
UBE2N P61088 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
MAPT P10636 2/20 0.39
RHOC P08134 1/20 0.39
RHOA P61586 1/20 0.39
F7 P08709 1/20 0.39
NPC1 O15118 2/20 0.39
TRPV1 Q8NER1 1/20 0.39
F10 P00742 3/20 0.39
HDAC6 Q9UBN7 2/20 0.38
RAB9A P51151 2/20 0.38
ALDH1A1 P00352 1/20 0.38
MCHR1 Q99705 1/20 0.38
POLB P06746 2/20 0.38
CASP3 P42574 1/20 0.38
SENP7 Q9BQF6 1/20 0.38
KLKB1 P03952 1/20 0.38
KLK1 P06870 1/20 0.38
ALOX5 P09917 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL6770182 0.97 NPC1 (0.42) RAD52UBE2NL3MBTL1NPC1TRPV1
Trifluoroacetic Acid SCHEMBL6775993 0.89 F10 (0.42) RAD52UBE2NL3MBTL1NPC1TRPV1
Trifluoroacetic Acid SCHEMBL6890249 0.84 F10 (0.49) NPC1TRPV1F10RAB9APOLB
Trifluoroacetic Acid SCHEMBL6769129 0.83 F10 (0.53) L3MBTL1RHOCRHOAF10ALDH1A1
Trifluoroacetic Acid SCHEMBL6769455 0.82 F10 (0.45) F7NPC1F10
Trifluoroacetic Acid SCHEMBL6770318 0.82 TRPV1 (0.42) MAPTNPC1TRPV1F10HDAC6
Trifluoroacetic Acid SCHEMBL6771038 0.81 ROCK1 (0.48) F7F10
Trifluoroacetic Acid SCHEMBL6765882 0.81 F10 (0.56) NPC1F10ALDH1A1KLKB1KLK1
SCHEMBL6775235 0.80 TBXAS1 (0.36) F10ALDH1A1
Trifluoroacetic Acid SCHEMBL6775615 0.80 F10 (0.60) L3MBTL1MAPTF10ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6825181-B1 ORALLY ADMINISTRATED TO EXHIBIT A STRONG ANTICOAGULANT EFFECT BY INHIBITING ACTIVATED BLOOD- COAGULATION FACTOR X AJINOMOTO CO., INC. (JP) 2004-11-30 US disclosed
EP-1065200-A1 AMINOISOQUINOLINE DERIVATIVES Ajinomoto Co., Inc. (JP) 2001-01-03 EP disclosed